Two more COVID-19 vaccines granted conditional usage approval in China
Updated
20:44, 25-Feb-2021
CGTN
Share
Copied
China's National Medical Products Administration (NMPA) on Thursday granted conditional usage approval to two COVID-19 vaccines developed by Sinopharm and CanSinoBIO.